Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Rouet 2017 US Patent

From Bioblast
Revision as of 12:47, 5 February 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Publication |title=Rouet P, Smih F (2017) ApoO for use in method for treating cancer and various pathophysiological situations. US Patent US20170035842 A1. |info=[https://ww...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Publications in the MiPMap
Rouet P, Smih F (2017) ApoO for use in method for treating cancer and various pathophysiological situations. US Patent US20170035842 A1.

Β» Open Access

Rouet P, Smih F (2017) US Patent

Abstract: The invention relates to a compound for use for inducing apoptosis in a cancerous cell, wherein said compound is selected from the group consisting of ApoO, a variant or a fragment thereof, their mixtures, and a vector encoding for said ApoO, variant or fragment thereof. The invention further relates to a compound for use for treating a pathophysiological situation, wherein said compound is an inhibitor of the ApoO activity or of the ApoO gene expression.

β€’ Bioblast editor: Kandolf G


Labels: MiParea: Respiration  Pathology: Cancer, Diabetes, Obesity 

Organism: Human, Mouse  Tissue;cell: Heart, Liver  Preparation: Isolated mitochondria 


Coupling state: LEAK, ET  Pathway: ROX  HRR: Oxygraph-2k 

Labels